LASR.NASDAQNlight, INC

Form 4: Nlight CEO Scott Keeney Executes Stock Option, Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Nlight's CEO, Scott Keeney, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On October 8th and 9th, 2024, Scott Keeney, the President and CEO of Nlight, Inc., engaged in transactions involving the company's common stock.
  • Keeney exercised stock options to acquire 15,000 shares on each day at a price of $0.75 per share.
  • Simultaneously, Keeney sold 15,000 shares on each day at weighted average prices of $11.15 and $11.11, respectively.
  • These sales were executed under a pre-arranged Rule 10b5-1 trading plan.
  • Following these transactions, Keeney continues to beneficially own 1,347,781 shares of Nlight common stock.
  • The stock options exercised were originally granted and became fully vested and exercisable on February 26, 2016.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock transactions by an executive under a pre-existing trading plan. There's no indication of positive or negative implications for the company.

Industry Context

This filing is a routine disclosure of insider transactions. It's common for executives to have pre-arranged trading plans (Rule 10b5-1) to avoid accusations of trading on inside information. The laser and photonics industry is competitive, and insider transactions are always scrutinized by investors.

Comparison to Industry Standards

  • Comparing Scott Keeney's transactions to other CEOs in the laser technology sector is difficult without specific data on their compensation structures and trading activities.
  • However, it's standard practice for executives at publicly traded companies like Coherent, IPG Photonics, and Lumentum to utilize 10b5-1 trading plans.
  • The volume and frequency of these transactions are generally dictated by individual financial planning and company policies.

Stakeholder Impact

  • The transactions could have a minor impact on shareholders due to the change in the number of shares outstanding, but the effect is likely minimal given the relatively small volume of shares traded compared to the total outstanding shares.
  • Employees are unlikely to be directly affected by these transactions.

Key Dates

DateDescription
02/26/2016Date the stock options became fully vested and exercisable.
10/08/2024Date of first reported transaction: exercise of stock options and sale of common stock.
10/09/2024Date of second reported transaction: exercise of stock options and sale of common stock.
10/10/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.